BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
251 hedge funds and large institutions have $6.04B invested in bluebird bio in 2018 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 98 increasing their positions, 76 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $8.48B → $6.04B (-$2.44B)
49% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 73
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
251
Holding in Top 10
1
Calls
$169M
Puts
$88.3M
Top Buyers
| 1 | +$300M | |
| 2 | +$178M | |
| 3 | +$33M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$28.5M |
| 5 |
Two Sigma Investments
New York
|
+$25.3M |
Top Sellers
| 1 | -$137M | |
| 2 | -$36.8M | |
| 3 | -$35.3M | |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$30.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$27.9M |